This research aims to investigate the connection between chronic pruritus, chronic prurigo, and elevated lymphoma risk.
Analysis of patient cohorts with chronic pruritus and chronic prurigo.
Identification of specific biomarkers linked to lymphoma risk.
Assessment of clinical management approaches.
Patients with chronic pruritus and chronic prurigo show a higher incidence of lymphoma.
Specific biomarkers are associated with this increased risk.
Importance of increased clinical vigilance in managing these patients is emphasized.
Abstract
CP and CPG patients have an increased lymphoma risk, linked to specific biomarkers, highlighting the importance of increased clinical vigilance in their management.